Cigarette smoking and major depression

Journal of Addictive Diseases

Volumn 17, Issue 1, 1998, Pages 35-46

  Covey, Lirio S ^a   Glassman, Alexander H ^a   Stetner, Fay ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ADULT; CIGARETTE SMOKING; CLINICAL ARTICLE; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; MOOD; RELAPSE; REVIEW; SMOKING; SMOKING CESSATION; WITHDRAWAL SYNDROME;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; PREVALENCE; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SMOKING CESSATION;

EID: 0031960435     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v17n01_04     Document Type: Article

References (28)

1. Glassman AH, Stetner F, Walsh BT, Raizman PS, Fleiss JL, Cooper TB, Covey LS. Heavy smokers, smoking cessation, and clonidine: Results of a double-blind, randomized trial. JAMA 1988;259:2863-2866.
2. Baldessarini RJ. Risk rates for depression. Arch Gen Psychiatry 1984; 41:103-104.
3. Glassman AH, Covey LS, Dalack GW, Stetner F, Rivelli SK, Fleiss JL, Cooper TB. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther 1993;54:670-679.
4. Ginsberg D, Hall SM, Reus VI, Munoz RF. Mood and depression diagnosis in smoking cessation. Experimental and Clinical Psychopharmacology 1995; 3:389-395.
5. Hall SM, Munoz RF, Reus VI. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol 1994; 62:141-146.
6. Niaura R, Goldstein MG, Depue J, Keuthen N, Kristeller J, Abrams D. Fluoxetine, symptoms of depression, and smoking cessation (abstract). Annals of Behavioral Medicine 1995;17, Suppl:S061.
7. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, Johnson J. Smoking, smoking cessation, and major depression. JAMA 1990;264: 1546-1549.
8. Breslau N. Psychiatric comorbidity of smoking and nicotine dependence. Behav Genet 1995;25:95-101.
9. Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ, Kessler RC. Smoking and major depression: A causal analysis. Arch Gen Psychiatry 1993; 50:36-43.
10. Covey LS, Hughes DC, Glassman AH, Blazer DG, George LK. Eversmoking, quitting, and psychiatric disorders: evidence from the Durham, North Carolina, Epidemiologic Catchment Area. Tobacco Control 1994;3:222-227.
11. Covey LS, Glassman AH, Stetner F. Depression and depressive symptoms in smoking cessation. Compr Psychiatry 1990;31:350-354.
12. Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: Findings from an epidemiologic study of young adults. Am J Psychiatry 1992;149:464-469.
13. Hughes JR. Tobacco withdrawal in self-quitters. J Consult Clin Psychol 1992;60:689-697.
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington DC: Amercian Psychiatric Association, 1987.
15. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
16. Fagerstrom KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978; 3:235-241.
17. Covey LS, Glassman AH, Stetner F. Major depression following smoking cessation. Am J Psychiatry 1997;154:263-265.
18. Keller MB, Lavori PW, Lewis CE, Klerman GL. Predictors of relapse in major depressive disorder. JAMA 1983;250:3299-3304.
19. Brown GW, Harris T. Social Origins of Depression. New York: Free Press, 1978.
20. Carmody TP. Affect regulation, nicotine addiction, and smoking cessation. J Psychoactive Drugs 1989;21:331-342.
21. Edwards NB, Simmons RC, Rosenthal TL, Hoon PW, Downs JM. Doxepin in the treatment of nicotine withdrawal. Psychosomatics 1988;29:203-206.
22. Ferry LH, Robbins AS, Scariati PD, Masterson A, Abbey DE, Burchette RJ. Enhancement of smoking cessation using the antidepressant, bupropion hydrochloride. Circulation 1992;86(4):I-671.(Abstract)
23. Hall SM. New directions in medications for the treatment of tobacco de-pendence. Washington, DC, March 15-17, 1996: Presented at the Society forResearch on Nicotine and Tobacco, 2nd Annual Conference.
24. Mizes JS, Sloan DM, Segraves K, Spring B, Pingatore R, Kristeller J. Fluoxetine and weight gain in smoking cessation: Examination of actual weight gain and fear of weight gain. Boca Raton, FL. Presented at The New Clinical Drug Evaluation Unit Program, 36th Annual Meeting, May 28-31, 1996.
25. Bock BC, Goldstein MG, Marcus BH. Depression following smoking cessation in women. J Subst Abuse 1996;8:137-144.
26. Foulds J. A role for dopamine in nicotine psychosis? Addiction 1991; 91: 1388-1389.
27. Hall SM, Munoz RF, Reus VI. Depression and smoking treatment: A clinical trial of an affect regulation treatment. NIDA Res Monogr 1992;119:326.
28. Zelman DC, Brandon TH, Jorenby DE, Baker TB. Measures of affect and nicotine dependence predict differential response to smoking cessation treatments. J Consult Clin Psychol 1992;60:943-952.